NuSkin Enterprises (NUS)

NYSE Mercado fechado

Nu Skin Enterprises, Inc. is a global beauty and wellness company that develops, markets, and sells personal care products, nutritional supplements, and related consumer technologies. The company is best known for the Nu Skin brand, which spans skin care, beauty devices, and anti-aging products, and Pharmanex, its wellness and nutrition line. Its products are distributed internationally through a direct selling model supported by independent sales leaders, social commerce tools, and local market operations.

Nu Skin reports its business across a broad geographic footprint that includes the Americas, Mainland China, Southeast Asia/Pacific, Japan, South Korea, Europe & Africa, and Hong Kong/Taiwan. This structure reflects the company’s reliance on local consumer preferences, regulatory environments, and distributor networks in each region. The Americas segment is a particularly important contributor, and wellness products represent a major part of total revenue.

Beyond its core branded consumer business, Nu Skin operates Rhyz, a strategic investment and operating platform. Rhyz includes manufacturing and packaging assets that support product development and supply chain capabilities, as well as other investments intended to broaden the company’s commercial reach. This gives Nu Skin exposure not only to consumer-facing beauty and wellness categories, but also to parts of the production infrastructure behind them.

The company competes in markets shaped by health-conscious consumers, premium skin care demand, and the growth of digital selling. Its performance depends on product innovation, brand engagement, distributor productivity, and the ability to navigate changing rules for direct selling and consumer products across global markets.

5.37 USD
5.19 USD
+0.05 (+0.94%)
Pós-mercado

Última atualização

Valor de mercado
260.72M
P/L
4.78
Preço/FCF
6.27
P/Receita
0.18
Valor da empresa
285.66M
Setor
Health Care
Indústria
Drugs, Drug Proprietaries, and Druggists' Sundries
Endereço
75 WEST CENTER ST, PROVO, UT, 84601
GlobeNewswire Inc.

Global Derma Roller Market Size To Worth USD 668.17 Million By 2033 | CAGR OF 8.22%

09 de set. de 2024, 19:00 PM
Zacks Investment Research

Nu Skin (NUS) Up 5.6% Since Last Earnings Report: Can It Continue?

07 de jun. de 2024, 12:30 PM
Zacks Investment Research

Nu Skin (NUS) Q1 Earnings Beat, Revenues Hurt by Currency Woes

09 de mai. de 2024, 11:23 AM
Zacks Investment Research

Nu Skin Enterprises (NUS) Surpasses Q1 Earnings Estimates

08 de mai. de 2024, 20:00 PM
Zacks Investment Research

Why Is Inter Parfums (IPAR) Down 4.1% Since Last Earnings Report?

28 de mar. de 2024, 12:30 PM
Zacks Investment Research

Nu Skin (NUS) Down 7.2% Since Last Earnings Report: Can It Rebound?

15 de mar. de 2024, 12:30 PM
Zacks Investment Research

Nu Skin (NUS) Q4 Earnings Top Estimates, Revenues Decline Y/Y

15 de fev. de 2024, 09:51 AM
Zacks Investment Research

Nu Skin Enterprises (NUS) Surpasses Q4 Earnings and Revenue Estimates

14 de fev. de 2024, 20:20 PM
Zacks Investment Research

Things to Consider Ahead of Nu Skin's (NUS) Q4 Earnings

12 de fev. de 2024, 09:49 AM
Zacks Investment Research

Philip Morris (PM) Lags Q4 Earnings Estimates

08 de fev. de 2024, 10:15 AM
Zacks Investment Research

Analysts Estimate Nu Skin Enterprises (NUS) to Report a Decline in Earnings: What to Look Out for

07 de fev. de 2024, 12:00 PM
Zacks Investment Research

Nu Skin (NUS) Down More Than 20% in 3 Months: Here's Why

13 de dez. de 2023, 14:50 PM
Zacks Investment Research

Why Is Inter Parfums (IPAR) Up 2.8% Since Last Earnings Report?

07 de dez. de 2023, 13:31 PM
Zacks Investment Research

Nu Skin (NUS) Up 1% Since Last Earnings Report: Can It Continue?

01 de dez. de 2023, 13:32 PM
Zacks Investment Research

Nu Skin (NUS) Misses Q3 Earnings Estimates, Lowers Guidance

02 de nov. de 2023, 12:44 PM
Zacks Investment Research

Why Nu Skin (NUS) Could Beat Earnings Estimates Again

30 de out. de 2023, 13:10 PM
Zacks Investment Research

e.l.f. Beauty (ELF) Readies for Q2 Earnings: Is a Beat Likely?

30 de out. de 2023, 12:05 PM
Zacks Investment Research

Things to Note Ahead of Nu Skin's (NUS) Q3 Earnings

30 de out. de 2023, 10:06 AM
Zacks Investment Research

Nu Skin Enterprises (NUS) Reports Next Week: Wall Street Expects Earnings Growth

25 de out. de 2023, 11:02 AM
Zacks Investment Research

Nu Vision 2025 Strategy Aids Nu Skin (NUS), High Costs Hurt

10 de out. de 2023, 10:10 AM
Valor de mercado
260.72M
Valor da empresa
285.66M
P/L
4.78
P/VP
0.33
P/Receita
0.18
VE / EBITDA
2.17
VE / Receita
0.2
LPA
1.12
Dividend yield
6.98%
Preço/FCF
6.27
P/Fluxo de caixa
3.43
Fluxo de caixa livre
41.57M
Retorno sobre patrimônio
6.87%
Retorno sobre ativos
3.96%
Dívida / Patrimônio
0.28
Índice de liquidez corrente
2.03
Índice de liquidez seca
1.34
Caixa
0.77
Volume médio
649.56K
Preço de referência fundamental
5.37

Demonstração de resultados

Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Receita 320.61M 370.32M 364.21M 386.14M 364.49M
Lucro bruto 214.46M 261.98M 256.72M 265.73M 246.96M
Lucro operacional 4.03M 23.24M 21.64M 30.78M -9.9M
EBITDA operacional 18.21M 36.16M 33.73M 43.83M 29.42M
Lucro líquido 1.84M 14.49M 17.08M 21.12M 107.52M
LPA básico 0.04 0.31 0.35 0.43 2.16
LPA diluído 0.04 0.27 0.34 0.43 2.14

Balanço patrimonial

Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Ativos totais 1.38B 1.41B 1.42B 1.44B 1.39B
Passivos totais 582.71M 600.07M 624.61M 655.94M 637.44M
Patrimônio líquido total 794.09M 805.24M 799.8M 787.75M 753.97M
Caixa e equivalentes 198.65M 238.63M 251.79M 264.16M 203.77M
Ativos circulantes 522.89M 547.7M 548.14M 571.55M 524.86M
Passivos circulantes 257M 263.73M 254.44M 283.91M 260.3M

Fluxo de caixa

Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Fluxo de caixa operacional -3.92M 16.62M 27.48M 35.8M 389K
Fluxo de caixa de investimento -14.29M -9.76M -9.92M 8.79M 181.54M
Fluxo de caixa de financiamento -20.4M -18.5M -26.88M 9.27M -166.3M
Variação no caixa -39.98M -13.16M -12.37M 60.39M 16.89M
Tipo Arquivamento Data URL
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 144 — NU SKIN ENTERPRISES, INC. Ver arquivamento
form 4 Form 4 — Winett James M Ver arquivamento
edgar index S-8 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 144 — NU SKIN ENTERPRISES, INC. Ver arquivamento
form 4 Form 4 — CAMPBELL DANIEL W Ver arquivamento
form 4 Form 4 — CAMPBELL DANIEL W Ver arquivamento
form 4 Form 4 — CAMPBELL DANIEL W Ver arquivamento
form 4 Form 4 — Thomas Pisano R. Ver arquivamento
form 4 Form 4 — Battle Emma S. Ver arquivamento
form 4 Form 4 — WOODBURY EDWINA D Ver arquivamento
form 4 Form 4 — WOODBURY EDWINA D Ver arquivamento
form 4 Form 4 — Zorko Mark A Ver arquivamento
form 4 Form 4 — Nathanson Laura Ver arquivamento
form 4 Form 4 — Winett James M Ver arquivamento
edgar index 8-K — NU SKIN ENTERPRISES, INC. Ver arquivamento
eight k text 8-K — 8-K Ver arquivamento
edgar index SD — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index SCHEDULE 13G/A — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 144 — NU SKIN ENTERPRISES, INC. Ver arquivamento
form 4 Form 4 — Nathanson Laura Ver arquivamento
edgar index 10-Q — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 8-K — NU SKIN ENTERPRISES, INC. Ver arquivamento
eight k text 8-K — 8-K Ver arquivamento
edgar index 8-K — NU SKIN ENTERPRISES, INC. Ver arquivamento
eight k text 8-K — 8-K Ver arquivamento
edgar index DEF 14A — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index DEFA14A — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index ARS — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 3 — NU SKIN ENTERPRISES, INC. Ver arquivamento
form 3 Form 3 — Lantz Chelsea K Ver arquivamento
edgar index SCHEDULE 13G/A — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 8-K — NU SKIN ENTERPRISES, INC. Ver arquivamento
eight k text 8-K — 8-K Ver arquivamento
edgar index 8-K — NU SKIN ENTERPRISES, INC. Ver arquivamento
eight k text 8-K — 8-K Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
form 4 Form 4 — WOODBURY EDWINA D Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 8-K — NU SKIN ENTERPRISES, INC. Ver arquivamento
eight k text 8-K — 8-K Ver arquivamento
form 4 Form 4 — NAPIERSKI RYAN S Ver arquivamento
form 4 Form 4 — Thomas James D Ver arquivamento
form 4 Form 4 — Clark Chayce David Ver arquivamento
form 4 Form 4 — Hatchett Steven Keith Ver arquivamento
form 4 Form 4 — Keisel Justin S Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
form 4 Form 4 — NAPIERSKI RYAN S Ver arquivamento
form 4 Form 4 — Thomas James D Ver arquivamento
form 4 Form 4 — Clark Chayce David Ver arquivamento
form 4 Form 4 — Hatchett Steven Keith Ver arquivamento
form 4 Form 4 — Keisel Justin S Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
edgar index 4 — NU SKIN ENTERPRISES, INC. Ver arquivamento
form 4 Form 4 — NAPIERSKI RYAN S Ver arquivamento
form 4 Form 4 — Thomas James D Ver arquivamento
form 4 Form 4 — Clark Chayce David Ver arquivamento